Acta Med. 2019, 62: 109-116
https://doi.org/10.14712/18059694.2019.134
Effect of Non-Surgical Periodontal Therapy on the Serum Sialic Acid Levels in Diabetic Patients with Periodontitis
References
1. GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4(1): 1–6.
<https://doi.org/10.1902/annals.1999.4.1.1>
2. JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010; 87(1): 4–14.
<https://doi.org/10.1016/j.diabres.2009.10.007>
3. H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993; 16(1): 329–34.
<https://doi.org/10.2337/diacare.16.1.329>
4. BA, Syed A, Izhar F, Ali Khan A. Bidirectional relationship between diabetes and periodontal disease: review of evidence. JPMA. The Journal of the Pakistan Medical Association 2010; 60(9): 766–8.
5. B, Brand-Miller J. The role and potential of sialic acid in human nutrition. European Journal of Clinical Nutrition 2003; 57(11): 1351–69.
<https://doi.org/10.1038/sj.ejcn.1601704>
6. ER, Kalivoda KA, Deszo EL, Steenbergen SM. Diversity of microbial sialic acid metabolism. Microbiology and Molecular Biology Reviews: MMBR 2004; 68(1): 132–53.
<https://doi.org/10.1128/MMBR.68.1.132-153.2004>
<PubMed>
7. P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. European Journal of Clinical Investigation 1999; 29(5): 413–25.
<https://doi.org/10.1046/j.1365-2362.1999.00485.x>
8. P, Poulsen AH, Andersen L, Skuldbol T, Fiehn NE. Oral infections and systemic diseases. Dent Clin North Am 2003; 47(3): 575–98.
<https://doi.org/10.1016/S0011-8532(03)00023-5>
9. GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007; 4: 3–10.
<https://doi.org/10.1111/j.1469-0691.2007.01798.x>
10. GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000; 79(1): 49–57.
<https://doi.org/10.1177/00220345000790010701>
11. F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005; 84(3): 269–73.
<https://doi.org/10.1177/154405910508400312>
12. G, Rastam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103(2): 123–9.
<https://doi.org/10.1016/0021-9150(93)90255-S>
13. MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999; 353(9165): 1649–52.
<https://doi.org/10.1016/S0140-6736(99)01046-6>
14. L, Felsenfeld H: The Biosynthesis of Sialic Acids. The Journal of Biological Chemistry 1962; 237(5).
15. SB, Bhaktha G. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients. Lipids Health Dis 2005; 4: 15.
<https://doi.org/10.1186/1476-511X-4-15>
<PubMed>
16. Rssdi CHB. Textbook of Diabetes Mellitus. New Delhi: Jaypee Brothers Medical Pub; 2012.
17. J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care 1996; 19(2): 130–4.
<https://doi.org/10.2337/diacare.19.2.130>
18. BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999; 22(9): 1543–8.
<https://doi.org/10.2337/diacare.22.9.1543>
19. G, Gibbons RJ. Accessible sialic acid content of oral epithelial cells from healthy and gingivitis subjects. J Periodontal Res 1990; 25(4): 250–3.
<https://doi.org/10.1111/j.1600-0765.1990.tb00912.x>
20. Usman K. Correlation between Non-insulin Dependant Diabetes Mellitus and Serum Sialic Acid. Annals 2009; 15(3).
21. HG, Bakhtiar H, Ahmed M. Relationships of salivary sialic acid and its fraction in periodontitis with demographic properties and medical history. IJDRD 2013, 3(2): 17–26.
22. PK, Pattabiraman TN. Salivary glycoproteins as indicators of oral diseases. Indian J Clin Biochem 2004; 19(1): 97–101.
<https://doi.org/10.1007/BF02872400>
<PubMed>
23. MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH. Rela tionship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Diabetes Care 2001; 24(2): 316–22.
<https://doi.org/10.2337/diacare.24.2.316>
24. H, Jensen JS, Jensen T, Deckert T. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J Intern Med 1995; 237(5): 519–23.
<https://doi.org/10.1111/j.1365-2796.1995.tb00878.x>
25. IA. Glycated haemoglobin; past, present, and future are we ready for the change. JPMA. The Journal of the Pakistan Medical Association 2011; 61(4): 383–8.
26. R, Ramraju B. Serum sialic acid values in healthy indian individuals. Ind J Med Res 1967; 55: 267–9.
27. MA, Earle K, Morocutti A, Yip J, Viberti G, Pickup JC. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 1994; 17(4): 305–10.
<https://doi.org/10.2337/diacare.17.4.305>
28. JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP. Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 1995; 18(8): 1100–3.
<https://doi.org/10.2337/diacare.18.8.1100>
29. JE, Swan RH, Hallmon WW. The glycosylated hemoglobin assay for diabetes: its value to the periodontist. Two case reports. Journal of Periodontology 1989; 60(11): 640–2.
<https://doi.org/10.1902/jop.1989.60.11.640>
30. Remesh A. Comparative evaluation of serum and salivary sialic acid, phosphodiesterase and nitric oxide levels in healthy and chronic periodontitis subjects. JSPIK 2010, 4(2).
31. Y, Ling J, Deng Y. The effect of non-surgical periodontal therapy on blood sugar level of non-insulin dependent diabetes mellitus diabetics with periodontitis. Zhonghua Kou Qiang Yi Xue Za Zhi 2000; 35(6): 444–6.
32. YH, Zhu BL. The effect of initial therapy on periodontal status and saccharified Hb (HbAIc) of patients with type II diabetes mellitus. Shanghai Kou Qiang Yi Xue 2004; 13(2): 150–1.
33. J, Suresh N, Fenol A, Vyloppillil R, Bhaskar A, Menon S. Comparison of glycated hemoglobin levels in individuals without diabetes and with and without periodontitis before and after non-surgical periodontal therapy. Journal of Periodontology 2014; 85(12): 1658–66.
<https://doi.org/10.1902/jop.2014.130661>
34. F, Firkova EI, Jun-Qi L, Xun H. Effect of non-surgical periodontal therapy on patients with type 2 diabetes mellitus. Folia Med (Plovdiv) 2007; 49(1–2): 32–6.
35. MA, Tutt P, Simpson H, Pickup JC. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta 1993; 219(1–2): 131–8.
<https://doi.org/10.1016/0009-8981(93)90204-H>
36. RE, Wolff LF, Michalowicz BS. A pilot study of glycosylated hemoglobin levels in periodontitis cases and healthy controls. Journal of Periodontology 2009; 80(7): 1057–61.
<https://doi.org/10.1902/jop.2009.080664>
37. A, Nilveus R, Egelberg J: Effect of non-surgical periodontal therapy (IV). Operator variability. J Clin Periodontol 1985; 12(3): 190–200.
<https://doi.org/10.1111/j.1600-051X.1985.tb00916.x>
38. PR, D’Hoore W, Bercy P. Comparative clinical responses related to the use of various periodontal instrumentation. J Clin Periodontol 2004; 31(3): 193–9.
<https://doi.org/10.1111/j.0303-6979.2004.00467.x>
39. Hinrichs JE, Novak MJ. Classfication of diseases and conditions affecting the periodontium. 11th ed. New Delhi: Reed Elsevier India Private Limited; 2012.
40. WHO: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: World Health Organisation; 1999.
41. R, Navarro A, Bascones A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. Journal of Periodontology 2006; 77(4): 591–8.
<https://doi.org/10.1902/jop.2006.050084>
42. A, Schmid B, Rutar A, Lang NP. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease. Journal of Periodontology 2000; 71(1): 14–21.
<https://doi.org/10.1902/jop.2000.71.1.14>
43. O, Kirzioglu FY, Ozdem M, Kocak H, Sutcu R, Sert T. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment. Oral Dis 2012; 18(3): 299–306.
<https://doi.org/10.1111/j.1601-0825.2011.01880.x>


